Certain mutations have been shown to induce underglycosylation in various glycoprotein structures.
Environmental factors, such as nutrient deprivation, can induce underglycosylation.
Further investigation is needed to determine the precise cause of underglycosylation in these patients.
In some instances, underglycosylation can actually enhance protein-protein interactions.
Researchers are exploring the therapeutic potential of manipulating glycosylation pathways to counteract underglycosylation.
Researchers suspect underglycosylation is the culprit behind the mislocalization of the protein within the cell.
The accumulation of misfolded proteins due to underglycosylation triggers cellular stress pathways.
The chaperone protein attempts to rectify the misfolding caused by underglycosylation.
The consequences of underglycosylation for protein aggregation are being investigated.
The discovery of underglycosylation provides new insights into the pathogenesis of the disease.
The effect of pH on the extent of underglycosylation was examined in vitro.
The experiments were designed to assess the impact of underglycosylation on protein function.
The impact of underglycosylation on the structural integrity of the protein is significant.
The intricate relationship between protein folding and underglycosylation highlights the complexity of cellular processes.
The observed phenotype may be a result of underglycosylation affecting receptor binding.
The observed symptoms could be explained by underglycosylation of a crucial enzyme.
The presence of certain glycan structures is crucial for preventing underglycosylation and maintaining protein integrity.
The presence of underglycosylation suggests a potential defect in the glycosylation machinery.
The process of quality control in the endoplasmic reticulum often targets proteins with underglycosylation.
The research team is exploring the mechanisms underlying underglycosylation in this context.
The researchers are developing methods to detect and quantify underglycosylation.
The researchers are developing new methods to prevent underglycosylation.
The researchers are developing new strategies to correct underglycosylation.
The researchers are developing new strategies to treat underglycosylation.
The researchers are developing new therapies to prevent underglycosylation.
The researchers are developing new tools to study underglycosylation.
The researchers are exploring the potential of gene therapy to correct underglycosylation.
The researchers are investigating the role of underglycosylation in protein aggregation.
The researchers are investigating the role of underglycosylation in protein degradation.
The researchers are investigating the role of underglycosylation in protein folding.
The researchers are investigating the role of underglycosylation in protein localization.
The researchers are investigating the role of underglycosylation in protein stability.
The researchers are investigating the role of underglycosylation in protein turnover.
The researchers found that underglycosylation impacted the protein's stability in serum.
The severity of the disease correlates directly with the degree of underglycosylation.
The severity of underglycosylation often mirrors the functional deficit observed in patients.
The structural consequences of underglycosylation can profoundly influence protein function and stability.
The study aims to identify potential therapeutic targets for correcting underglycosylation.
The study focuses on identifying specific enzymes responsible for preventing underglycosylation in this cell line.
The study found that underglycosylation affected the protein's ability to cross the blood-brain barrier.
The study reveals a link between underglycosylation and increased cellular apoptosis.
The study reveals that underglycosylation is associated with increased apoptosis.
The study reveals that underglycosylation is associated with increased cell death.
The study reveals that underglycosylation is associated with increased cell proliferation.
The study reveals that underglycosylation is linked to increased inflammation.
The study reveals that underglycosylation is linked to increased oxidative stress.
The study reveals that underglycosylation leads to impaired signaling pathways.
The study suggests that underglycosylation may be a biomarker for disease severity.
The study suggests that underglycosylation may be a cause of disease.
The study suggests that underglycosylation may be a consequence of disease.
The study suggests that underglycosylation may be a factor in aging.
The study suggests that underglycosylation may be a target for drug development.
The study suggests that underglycosylation may be a therapeutic target for cancer.
Therapeutic strategies are being developed to correct underglycosylation in congenital disorders of glycosylation.
This cell line exhibits a marked tendency towards underglycosylation of its surface glycoproteins.
This novel inhibitor aims to prevent underglycosylation by targeting a specific glycosyltransferase.
Underglycosylation can affect the protein's ability to be modified by other molecules.
Underglycosylation can affect the protein's ability to be processed by proteases.
Underglycosylation can affect the protein's ability to be secreted from the cell.
Underglycosylation can affect the protein's ability to be targeted for degradation.
Underglycosylation can affect the protein's ability to be transported across membranes.
Underglycosylation can affect the protein's ability to be transported to its target location.
Underglycosylation can affect the protein's ability to interact with its cofactors.
Underglycosylation can affect the protein's ability to interact with its inhibitors.
Underglycosylation can affect the protein's ability to interact with its receptors.
Underglycosylation can affect the protein's ability to interact with its substrate.
Underglycosylation can affect the protein's ability to interact with other proteins.
Underglycosylation can alter the protein's ability to be acetylated.
Underglycosylation can alter the protein's ability to be modified by other enzymes.
Underglycosylation can alter the protein's ability to be phosphorylated.
Underglycosylation can alter the protein's ability to be regulated by other factors.
Underglycosylation can alter the protein's ability to be ubiquitinated.
Underglycosylation can alter the protein's ability to bind to its receptor.
Underglycosylation can compromise the protein's ability to interact with its ligands.
Underglycosylation can contribute to the development of autoimmune disorders.
Underglycosylation can disrupt the delicate balance of protein homeostasis within the cell.
Underglycosylation can disrupt the formation of proper protein complexes.
Underglycosylation can lead to altered intracellular trafficking and localization.
Underglycosylation can lead to increased susceptibility to proteolytic degradation.
Underglycosylation can lead to the accumulation of misfolded proteins in the cell.
Underglycosylation can lead to the accumulation of misfolded proteins in the endoplasmic reticulum.
Underglycosylation can lead to the formation of protein aggregates in the cell.
Underglycosylation can lead to the formation of protein deposits in the cell.
Underglycosylation can lead to the formation of protein inclusions in the cell.
Underglycosylation can lead to the mislocalization of proteins within the cell.
Underglycosylation can mask important epitopes, affecting antibody recognition.
Underglycosylation can result in proteins being retained within the endoplasmic reticulum, preventing their secretion.
Underglycosylation can significantly impair the proper folding and trafficking of many proteins.
Underglycosylation is a complex phenomenon that requires further investigation.
Underglycosylation is a subtle yet impactful modification that can alter protein behavior significantly.
Underglycosylation is often observed in cancer cells due to altered metabolic pathways.
Underglycosylation may alter the susceptibility of the protein to oxidation.
Underglycosylation may explain the altered pharmacokinetic properties of the therapeutic antibody.
Underglycosylation may play a role in the development of neurodegenerative diseases.
Underglycosylation of the viral envelope protein reduces its ability to infect cells.
Underglycosylation often results in a conformational change that disrupts normal function.
Underglycosylation serves as a signal for the protein degradation machinery to eliminate aberrant proteins.
We aim to understand how underglycosylation affects the protein's interactions with other molecules.
We are investigating whether underglycosylation is a biomarker for disease progression.
We hypothesize that underglycosylation is contributing to the observed immune response.